GNI Group Ltd.
Notice on the Completion of Acquisition of All Shares of Ayumi Pharmaceutical Holdings Co., Ltd. (Full Subsidiary) and Full Payment for New Shares Issued through Third-Party Allotment (In-Kind Contribution)
Completed acquisition to become a wholly owned subsidiary and issuance of new shares through a third-party allotment. Payment date is July 1, 2026; issued shares: 9,974,291; issue price: 2,684 JPY per share; funds raised: approximately 26.771 billion JPY. Invested entities: BCP Asia AYM Holding (Cayman) L.P., Toho Holdings, and Hisamitsu Pharmaceutical.
Key Figures
- Number of newly issued shares: 9,974,291 shares
- Issue price: 2,684 JPY per share
- Amount of funds raised: 26,770,997,044 JPY
- Total issued shares after the capital increase: 65,817,418 shares
- Total issued shares before the capital increase: 55,843,127 shares
AI要約
Overview
Today, Ayumi Pharmaceutical Holdings Co., Ltd. announced that it has acquired all shares of Ayumi Pharmaceutical Holdings Co., Ltd. to become a wholly owned subsidiary. In addition, the payment procedures for the new shares issued through a third-party allotment in connection with an in-kind contribution based on the June 5, 2016 resolution have been completed. The new shares have been allocated to three parties: BCP Asia AYM Holding (Cayman) L.P., Toho Holdings, and Hisamitsu Pharmaceutical, with funding amounting to approximately 26.771 billion JPY.
Impact on finances going forward
The impact on this term's consolidated results is currently under review. Further disclosures will be provided as soon as they are available. The total number of shares after the capital increase will be 65,817,418, which may have dilutive effects on shareholder equity.
Ayumi Pharmaceutical Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
